Home » ARIAD LOSES BID TO END AMGEN LAWSUIT
ARIAD LOSES BID TO END AMGEN LAWSUIT
Ariad Pharmaceuticals Inc., a developer of drugs to treat cancer, said Tuesday a federal court denied its motion to dismiss a lawsuit filed against it by biotechnology company Amgen Inc.
Los Angeles Business (http://losangeles.bizjournals.com/losangeles/stories/2006/09/11/daily14.html?surround=lfn)
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
21Oct